Eurasian Hematology-Oncology Group

http://www.ehog.net/

 

Xth Eurasian Hematology-Oncology Congress
C

Perioperative Systemic Therapy for Localized Renal Cell Carcinoma: To Treat or Not to Treat?

By Xth Eurasian Hematology-Oncology Congress FEATURING Cagatay Arslan
By Xth Eurasian Hematology-Oncology Congress FEATURING Cagatay Arslan
53 views
December 4, 2019
0 Comments
Login to view comments. Click here to Login

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay
Genitourinary
18:54
Xth Eurasian Hematology-Oncology Congress

Stage I Testicular Cancer: Who Needs Treatment and Which One?

Feat. O. Dizdar
14:30
Xth Eurasian Hematology-Oncology Congress

How to Treat Cisplatin-Ineligible Metastatic Bladder Cancer: CPi Str…

Feat. A. Karaoglu
06:15
Xth Eurasian Hematology-Oncology Congress

How to Treat Cisplatin-Ineligible Metastatic Bladder Cancer: Non-Cis…

Feat. A. Karaoglu
16:18
Xth Eurasian Hematology-Oncology Congress

What is the Role and Best Sequencing of the New Generation Hormonal …

Feat. M. Erman
17:28
Xth Eurasian Hematology-Oncology Congress

What is the Role and Best Sequencing of the New Generation Hormonal …

Feat. M. Erman
26:23
Xth Eurasian Hematology-Oncology Congress

Perioperative Systemic Therapy for Localized Renal Cell Carcinoma: T…

Feat. C. Arslan